NCT01781793View on ClinicalTrials.gov

Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Lung; Disease, Interstitial, With Fibrosis
Interventions
OTHER

Room air

Humidified room air (21% oxygen) will be inspired

OTHER

Hyperoxia

60% oxygen will be inspired

Trial Locations (1)

V6Z1Y6

UBC James Hogg Research Centre, St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01781793 - Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease | Biotech Hunter | Biotech Hunter